Urinary matrix metalloproteinase-8 and -9 activities in type 2 diabetic subjects: A marker of incipient diabetic

Nynke J van der Zijl1, Roeland Hanemaaijer, Maarten E Tushuizen

  • 1Department of Endocrinology/Diabetes Center, VU University Medical Center, Amsterdam, The Netherlands. nj.vdzijl@vumc.nl

Clinical Biochemistry
|February 27, 2010
PubMed

Insights

Urinary matrix metalloproteinases (MMPs), particularly MMP-8 and MMP-9, are elevated in patients with type 2 diabetes and albuminuria, indicating a link to kidney function decline.

Area of Science:

  • Nephrology
  • Endocrinology
  • Biochemistry

Background:

  • Diabetic nephropathy (DN) is a significant complication of type 2 diabetes mellitus (T2DM).
  • Matrix metalloproteinases (MMPs) are implicated in the pathophysiological processes underlying DN.
  • Urinary MMP activity may serve as a biomarker for renal function decline in T2DM.

Purpose of the Study:

  • To investigate the relationship between urinary MMP activity and renal function in T2DM patients.
  • To compare MMP levels in T2DM patients with and without albuminuria (UA) against healthy controls (CO).
  • To identify clinical determinants associated with elevated MMP levels in T2DM.

Main Methods:

  • Quantification of MMP-2, MMP-8, and MMP-9 activity in 24-hour urine collections.
  • Study groups included T2DM patients with albuminuria (UA, n=27), T2DM patients without albuminuria (NA, n=48), and controls (CO, n=28).
  • Analysis of risk factors for DN, including age, diabetes duration, BMI, blood pressure, glucose levels, HbA1c, and renal function.

Main Results:

  • MMP-8 and MMP-9 levels were significantly higher in UA patients compared to NA and CO groups (P<0.01).
  • Elevated MMP levels were observed in 93% of UA patients, 78% of NA patients, and 46% of CO.
  • MMP-8 and MMP-9 levels were significantly associated with age, diabetes duration, BMI, systolic blood pressure, fasting plasma glucose, HbA1c, and renal function (P<0.05).

Conclusions:

  • MMP-8 and MMP-9 are elevated in T2DM patients with albuminuria, suggesting a role in DN pathogenesis.
  • MMP-9 demonstrated the strongest correlation with clinical parameters associated with diabetic nephropathy.
  • Urinary MMP activity, particularly MMP-9, may serve as a valuable biomarker for assessing renal function and DN progression in T2DM.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.